tirzepatide and vision problems Popular weight-loss drugs linked to sudden loss, research suggests Ophthalmic complications observed in patients

Your healthcare provider can help assess whether discontinuation is appropriate, establish monitoring protocols, arrange alternative therapies if needed, and ensure safe transition off tirzepatide while maintaining optimal management of your underlying health conditions

More recently, a randomised controlled trial of lixisenatide in early Parkinson's disease (the LIXIPARK study) was published in the New England Journal of Medicine (2024)

One palm-sized portion of protein (approximately 4 ounces)

Pair it with lifestyle: Supplements work best when they "supplement" a healthy life

Direct Comparison to Other Weight Loss Treatments When compared directly to other weight loss options available to Irish patients: Mounjaro demonstrated approximately 30% greater weight loss than Wegovy (semaglutide) in clinical trials Weight loss was 3-4 times greater than with older medications like Saxenda (liraglutide) Results approached those of bariatric surgery but without permanent anatomical changes Improvements in metabolic health markers were more pronounced than with other medications These comparative advantages have created significant demand for Mounjaro among Irish patients seeking the most effective non-surgical weight management option